Curanex Pharmaceuticals Inc
CURX
$0.32
-$0.01-3.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.23M | -1.30M | -435.00K | -418.90K | -361.50K |
| Total Depreciation and Amortization | 79.30K | 45.00K | 29.60K | 14.60K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 74.70K | 70.30K | 74.70K | 74.70K |
| Change in Net Operating Assets | -6.34M | -8.54M | -330.30K | -282.10K | -268.80K |
| Cash from Operations | -10.48M | -9.72M | -665.30K | -611.50K | -555.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 400.00K | 200.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.66M | 15.66M | 0.00 | 580.00K | 630.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 100.00 | 100.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -346.50K | -346.50K | -- | -- | -- |
| Cash from Financing | 15.31M | 15.31M | 400.00K | 780.10K | 630.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 4.82M | 5.59M | -265.30K | 168.60K | 74.60K |